Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

607

Participants

Timeline

Start Date

February 8, 2013

Primary Completion Date

March 23, 2015

Study Completion Date

March 23, 2015

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Linagliptin

tablet

DRUG

Empagliflozin + Linagliptin

Fixed dose combination.

DRUG

Empagliflozin + Linagliptin

Fixed dose combination

DRUG

Empagliflozin + Linagliptin

Fixed dose combination

DRUG

Empagliflozin placebo + Linagliptin placebo

Matching Empagliflozin + Linagliptin low dose

DRUG

Empagliflozin + Linagliptin

Fixed dose combination.

Trial Locations (90)

Unknown

1275.9.01013 Boehringer Ingelheim Investigational Site, Gulf Shores

1275.9.01009 Boehringer Ingelheim Investigational Site, Norwalk

1275.9.01015 Boehringer Ingelheim Investigational Site, San Diego

1275.9.01017 Boehringer Ingelheim Investigational Site, San Diego

1275.9.01011 Boehringer Ingelheim Investigational Site, Northglenn

1275.9.01010 Boehringer Ingelheim Investigational Site, Coral Gables

1275.9.01004 Boehringer Ingelheim Investigational Site, Miami

1275.9.01006 Boehringer Ingelheim Investigational Site, Oldsmar

1275.9.01001 Boehringer Ingelheim Investigational Site, Palm Coast

1275.9.01027 Boehringer Ingelheim Investigational Site, Port Orange

1275.9.01029 Boehringer Ingelheim Investigational Site, Blue Ridge

1275.9.01003 Boehringer Ingelheim Investigational Site, Marietta

1275.9.01022 Boehringer Ingelheim Investigational Site, Savannah

1275.9.01031 Boehringer Ingelheim Investigational Site, Chicago

1275.9.01019 Boehringer Ingelheim Investigational Site, Methuen

1275.9.01024 Boehringer Ingelheim Investigational Site, Troy

1275.9.01023 Boehringer Ingelheim Investigational Site, St Louis

1275.9.01002 Boehringer Ingelheim Investigational Site, Omaha

1275.9.01007 Boehringer Ingelheim Investigational Site, Newington

1275.9.01016 Boehringer Ingelheim Investigational Site, Asheboro

1275.9.01025 Boehringer Ingelheim Investigational Site, Burlington

1275.9.01014 Boehringer Ingelheim Investigational Site, Shelby

1275.9.01028 Boehringer Ingelheim Investigational Site, Winston-Salem

1275.9.01018 Boehringer Ingelheim Investigational Site, Dayton

1275.9.01005 Boehringer Ingelheim Investigational Site, Corvallis

1275.9.01032 Boehringer Ingelheim Investigational Site, Corpus Christi

1275.9.01030 Boehringer Ingelheim Investigational Site, Houston

1275.9.01021 Boehringer Ingelheim Investigational Site, San Antonio

1275.9.61009 Boehringer Ingelheim Investigational Site, Liverpool

1275.9.61001 Boehringer Ingelheim Investigational Site, St Leonards

1275.9.61003 Boehringer Ingelheim Investigational Site, Carina Heights

1275.9.61002 Boehringer Ingelheim Investigational Site, Herston

1275.9.61006 Boehringer Ingelheim Investigational Site, Malvern

1275.9.61007 Boehringer Ingelheim Investigational Site, Nedlands

1275.9.55002 Boehringer Ingelheim Investigational Site, Brasília

1275.9.55005 Boehringer Ingelheim Investigational Site, Goiânia

1275.9.55001 Boehringer Ingelheim Investigational Site, São Paulo

1275.9.55003 Boehringer Ingelheim Investigational Site, São Paulo

1275.9.55004 Boehringer Ingelheim Investigational Site, São Paulo

1275.9.01101 Boehringer Ingelheim Investigational Site, Burnaby

1275.9.01103 Boehringer Ingelheim Investigational Site, Victoria

1275.9.01105 Boehringer Ingelheim Investigational Site, Cornwall

1275.9.01106 Boehringer Ingelheim Investigational Site, Hamilton

1275.9.01104 Boehringer Ingelheim Investigational Site, Toronto

1275.9.01102 Boehringer Ingelheim Investigational Site, Waterloo

1275.9.34008 Boehringer Ingelheim Investigational Site, Barcelona

1275.9.33006 Boehringer Ingelheim Investigational Site, Bourg-des-Comptes

1275.9.33008 Boehringer Ingelheim Investigational Site, Dessenheim

1275.9.33003 Boehringer Ingelheim Investigational Site, La Riche

1275.9.33012 Boehringer Ingelheim Investigational Site, Paris

1275.9.33002 Boehringer Ingelheim Investigational Site, Saint-Avertin

1275.9.33005 Boehringer Ingelheim Investigational Site, Savonnières

1275.9.33004 Boehringer Ingelheim Investigational Site, Tours

1275.9.64005 Boehringer Ingelheim Investigational Site, Auckland, New Zealand

1275.9.64006 Boehringer Ingelheim Investigational Site, Auckland, New Zealand

1275.9.64008 Boehringer Ingelheim Investigational Site, Birkenhead Auckland

1275.9.64007 Boehringer Ingelheim Investigational Site, Christchurch Central

1275.9.64004 Boehringer Ingelheim Investigational Site, Christchurch, New Zealand

1275.9.64002 Boehringer Ingelheim Investigational Site, Otahuhu Auckland

1275.9.64001 Boehringer Ingelheim Investigational Site, Takapuna Auckland

1275.9.64003 Boehringer Ingelheim Investigational Site, Tauranga, New Zealand

1275.9.47001 Boehringer Ingelheim Investigational Site, Bergen

1275.9.47002 Boehringer Ingelheim Investigational Site, Oslo

1275.9.47003 Boehringer Ingelheim Investigational Site, Oslo

1275.9.47007 Boehringer Ingelheim Investigational Site, Oslo

1275.9.47006 Boehringer Ingelheim Investigational Site, Svelvik

1275.9.82006 Boehringer Ingelheim Investigational Site, Daejeon

1275.9.82009 Boehringer Ingelheim Investigational Site, Deagu

1275.9.82002 Boehringer Ingelheim Investigational Site, Goyang

1275.9.82004 Boehringer Ingelheim Investigational Site, Seongnam

1275.9.82001 Boehringer Ingelheim Investigational Site, Seoul

1275.9.82005 Boehringer Ingelheim Investigational Site, Seoul

1275.9.82007 Boehringer Ingelheim Investigational Site, Seoul

1275.9.82008 Boehringer Ingelheim Investigational Site, Seoul

1275.9.82010 Boehringer Ingelheim Investigational Site, Seoul

1275.9.34011 Boehringer Ingelheim Investigational Site, A Coruña

1275.9.34009 Boehringer Ingelheim Investigational Site, Alicante

1275.9.34005 Boehringer Ingelheim Investigational Site, Badía Del Vallès - Barcelona

1275.9.34001 Boehringer Ingelheim Investigational Site, Barcelona

1275.9.34003 Boehringer Ingelheim Investigational Site, Barcelona

1275.9.34004 Boehringer Ingelheim Investigational Site, Barcelona

1275.9.34002 Boehringer Ingelheim Investigational Site, Seville

1275.9.34010 Boehringer Ingelheim Investigational Site, Valencia

1275.9.34006 Boehringer Ingelheim Investigational Site, Vic

1275.9.88606 Boehringer Ingelheim Investigational Site, Kaohsiung City

1275.9.88607 Boehringer Ingelheim Investigational Site, Kaohsiung City

1275.9.88602 Boehringer Ingelheim Investigational Site, New Taipei City

1275.9.88603 Boehringer Ingelheim Investigational Site, Taichung

1275.9.88604 Boehringer Ingelheim Investigational Site, Taichung

1275.9.88605 Boehringer Ingelheim Investigational Site, Tainan City

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY